Investors’ attention has returned to the pharmaceutical sector, following the evolution of vaccine research as the situation continues to deteriorate, despite the arrival of the warm season, according to an analysis by brokerage firm XTB Romania. Representatives of the brokerage firm say that assessing progress on a vaccine is not easy, as the number of products under investigation and the speed of work are unprecedented.

https://www.agerpres.ro/economic-intern/2020/07/09/xtb-romania-producatorii-de-vaccinuri-in-atentia-investitorilor-romani-la-bursa–537365